Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherTHERAPY

Value of Recombinant Human Thyrotropin in High-Dose Radioiodine Therapy: A Case Report

Vika Müller, Karl H. Bohuslavizki, Susanne Klutmann and Malte Clausen
Journal of Nuclear Medicine Technology December 2002, 30 (4) 185-188;
Vika Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl H. Bohuslavizki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Klutmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malte Clausen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Sagittal T1-weighted spinecho image of thoracic spine. Note space-occupying lesion in third thoracic vertebra compressing spinal cord. SP = spinal cord.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Conventional hematoxylin-eosin staining of space-occupying lesion of Figure 1 shows numerous cells from well-differentiated follicular carcinoma. Original magnification, 400×.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Whole-body scans from anterior views (top row) and spot images from left lateral views (bottom row). Images obtained after first radioiodine therapy (A) show 2 foci of intense iodine uptake (arrows) in thyroid bed and in thoracic spine, whereas images obtained 3 mo later after second radioiodine therapy (C) show significantly decreased iodine avidity in both lesions (arrows), thereby demonstrating therapeutic efficacy. (B) PET images obtained after first radioiodine therapy show no increased glucose metabolism in thyroid bed or in thoracic spine (arrows) but in lateral cervical muscles.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 30 (4)
Journal of Nuclear Medicine Technology
Vol. 30, Issue 4
December 1, 2002
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Value of Recombinant Human Thyrotropin in High-Dose Radioiodine Therapy: A Case Report
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Value of Recombinant Human Thyrotropin in High-Dose Radioiodine Therapy: A Case Report
Vika Müller, Karl H. Bohuslavizki, Susanne Klutmann, Malte Clausen
Journal of Nuclear Medicine Technology Dec 2002, 30 (4) 185-188;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Value of Recombinant Human Thyrotropin in High-Dose Radioiodine Therapy: A Case Report
Vika Müller, Karl H. Bohuslavizki, Susanne Klutmann, Malte Clausen
Journal of Nuclear Medicine Technology Dec 2002, 30 (4) 185-188;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
  • Google Scholar

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire